RxDoctor Payments Data

Shannon Clark, MD

Neurological Surgery · Norfolk, VANPI 1316258569

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,411 of the $17,238 with a category attached, or 66.2%. 20 manufacturers reported payments, led by Medtronic at 47.0% of the total.

$17,238in general payments, 2019–2025

Across 213 payments — averaging $80.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Boston Scientific$3K
  • Spineology Inc.$3K
  • Aesculap Implant Systems, LLC$846
  • Globus Medical$688
  • Abbott$383
  • plus $2K from 14 others
$6,053in research payments, 2019–2025

Across 2 payments — averaging $3026.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$3K
  • Nevro Corp.$3K

What the payments were for

  • Consulting fees$3002%
  • Travel & lodging$5,52732%
  • Food & beverage$11,41166%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,238 in reported general payments places this provider in the 80th percentile of 156 neurological surgery providers in Virginia.

See all neurological surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$320,550
Medicare patients
517
Services billed
1,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin75$573
Pregabalin13$439
Nabumetone45$260
Duloxetine Hcl15$179
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$124
Methocarbamol28$108
Ibuprofen12$79
Oxycodone Hcl14$78

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →